National Healthcare Economics and Policy Expert Ruben Jose King-Shaw Jr Joins CURE Pharmaceutical’s Board of Directors
29. Januar 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced Ruben Jose King-Shaw Jr. has joined its Board...